1185 related articles for article (PubMed ID: 12576814)
1. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
Goel MC; Mahendra V; Roberts JG
J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
Patel A; Soonawalla P; Shepherd SF; Dearnaley DP; Kellett MJ; Woodhouse CR
J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
[TBL] [Abstract][Full Text] [Related]
3. 13-year experience with percutaneous management of upper tract transitional cell carcinoma.
Clark PE; Streem SB; Geisinger MA
J Urol; 1999 Mar; 161(3):772-5; discussion 775-6. PubMed ID: 10022682
[TBL] [Abstract][Full Text] [Related]
4. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup.
Palou J; Piovesan LF; Huguet J; Salvador J; Vicente J; Villavicencio H
J Urol; 2004 Jul; 172(1):66-9. PubMed ID: 15201739
[TBL] [Abstract][Full Text] [Related]
6. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Chen GL; Bagley DH
J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360
[TBL] [Abstract][Full Text] [Related]
7. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic management of upper tract urothelial tumors.
Stoller ML; Gentle DL; McDonald MW; Reese JH; Tacker JR; Carroll PR; Best C
Tech Urol; 1997; 3(3):152-7. PubMed ID: 9422447
[TBL] [Abstract][Full Text] [Related]
9. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH
J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
[TBL] [Abstract][Full Text] [Related]
10. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome.
Jabbour ME; Desgrandchamps F; Cazin S; Teillac P; Le Duc A; Smith AD
J Urol; 2000 Apr; 163(4):1105-7; quiz 1295. PubMed ID: 10737475
[TBL] [Abstract][Full Text] [Related]
12. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma.
Keeley FX; Bibbo M; Bagley DH
J Urol; 1997 May; 157(5):1560-5. PubMed ID: 9112476
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous nephroscopic resection of renal pelvic tumors.
Fuglsig S; Krarup T
Scand J Urol Nephrol Suppl; 1995; 172():15-7. PubMed ID: 8578249
[TBL] [Abstract][Full Text] [Related]
14. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience.
Rouprêt M; Hupertan V; Sanderson KM; Harmon JD; Cathelineau X; Barret E; Vallancien G; Rozet F
Urology; 2007 Apr; 69(4):656-61. PubMed ID: 17445646
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous therapy of low stage and grade urothelial neoplasia: long-term follow up.
Montanari E; Del Nero A; Bernardini P; Mangiarotti B; Confalonieri S; Grisotto M; Cordima G
Arch Ital Urol Androl; 2005 Dec; 77(4):211-4. PubMed ID: 16444935
[TBL] [Abstract][Full Text] [Related]
16. Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma.
Wu CF; Shee JJ; Ho DR; Chen WC; Chen CS
J Urol; 2004 Jan; 171(1):126-9. PubMed ID: 14665859
[TBL] [Abstract][Full Text] [Related]
17. Intermediate followup of hand assisted laparoscopic nephroureterectomy for urothelial carcinoma: factors associated with outcomes.
Wolf JS; Dash A; Hollenbeck BK; Johnston WK; Madii R; Montgomery JS
J Urol; 2005 Apr; 173(4):1102-7. PubMed ID: 15758710
[TBL] [Abstract][Full Text] [Related]
18. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
Walton TJ; Sherwood BT; Parkinson RJ; Obakponovwe O; Thomas SA; Taylor MC; England RC; Lemberger RJ
J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma.
Manabe D; Saika T; Ebara S; Uehara S; Nagai A; Fujita R; Irie S; Yamada D; Tsushima T; Nasu Y; Kumon H;
Urology; 2007 Mar; 69(3):457-61. PubMed ID: 17382144
[TBL] [Abstract][Full Text] [Related]
20. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection.
Rouprêt M; Traxer O; Tligui M; Conort P; Chartier-Kastler E; Richard F; Cussenot O
Eur Urol; 2007 Mar; 51(3):709-13; discussion 714. PubMed ID: 16911852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
